Articles related to Oncology, Radiation

AI’s transformative role in breast cancer care goes beyond prediction—it offers a nuanced evaluation of both cancerous and non-cancerous elements, guiding individualized treatment plans. Learn how this innovation minimizes unnecessary chemotherapy, prioritizes patient outcomes, and heralds a new era in precision medicine.

The future of advanced bladder cancer treatment has been crystallized by the findings of the EV302 study, which demonstrated a median overall survival of 31.5 months with enfortumab vedotin-ejfv plus pembrolizumab.

The GCIG INTERLACE study has demonstrated a significant improvement in 5-year survival rates in advanced cervical cancer, from 72% to 80%, with the addition of induction chemotherapy to standard-of-care chemoradiation.

The management of low-risk prostate cancer has seen a significant shift over the last two decades, with active surveillance increasingly becoming the preferred approach. However, despite this progress, the overtreatment of low-risk disease remains a concern, underscoring the need for continued refinement in patient selection and monitoring strategies.

In a recent study, researchers found that vaginal estrogen therapy does not increase the risk of death in patients with breast cancer. In fact, it may even decrease the risk of breast cancer-specific death and all-cause death.

The escalating crisis of burnout among oncology healthcare workers is a pressing issue that demands immediate attention. With up to 54% of doctors and nurses experiencing burnout, the need for systemic changes in the healthcare landscape has never been more urgent.